BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Receives Average Recommendation of "Moderate Buy" from Analysts
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX - Get Free Report) has earned an average rating of "Moderate Buy" from the fourteen analysts that are currently covering the company, MarketBeat.com...